Literature DB >> 20050999

Re-exposure to heparin in uremic patients requiring hemodialysis with heparin-induced thrombocytopenia.

K Wanaka, T Matsuo, M Matsuo, C Kaneko, K Miyashita, R Asada, H Matsushima, Y Nakajima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20050999     DOI： 10.1111/j.1538-7836.2009.03734.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  5 in total

Review 1.  Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Lori-Ann Linkins; Antonio L Dans; Lisa K Moores; Robert Bona; Bruce L Davidson; Sam Schulman; Mark Crowther
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Hats Off to HIT: A Case Report.

Authors:  Akhwand Shakeel Ahmad; Dhia Jaber Al-Layla; Manjula Dhinakar
Journal:  Oman Med J       Date:  2012-05

3.  Nattokinase-heparin exhibits beneficial efficacy and safety-an optimal strategy for CKD patients on hemodialysis.

Authors:  Hao Wu; Huan Wang; Wei Li; Chi Zhang; Yushan Liu; Feng Xu; Jiepeng Chen; Lili Duan; Fengjiao Zhang
Journal:  Glycoconj J       Date:  2019-02-20       Impact factor: 2.916

Review 4.  Diagnosis and management of heparin-induced thrombocytopenia.

Authors:  Grace M Lee; Gowthami M Arepally
Journal:  Hematol Oncol Clin North Am       Date:  2013-04-13       Impact factor: 3.722

5.  Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia.

Authors:  Tamam Bakchoul; Andreas Greinacher
Journal:  Ther Adv Hematol       Date:  2012-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.